Litcius/Paper detail

Designing and Implementing a Population-based Organised Prostate Cancer Testing Programme

Max Alterbeck, Emil Järbur, Erik Thimansson, Jonas Wallström, Johan Bengtsson, Thomas Björk‐Eriksson, Anders Bjartell, Ola Bratt, Thomas Jiborn, Rebecka Arnsrud Godtman

2022European Urology Focus40 citationsDOIOpen Access PDF

Abstract

BackgroundEuropean guidelines recommend that well-informed men at elevated risk of having prostate cancer (PCa) should be offered prostate-specific antigen (PSA) testing with risk-stratified follow-up. The Swedish National Board of Health and Welfare recommends against screening for PCa but supports regional implementation of organised prostate cancer testing (OPT).ObjectiveTo report the process for designing and implementing OPT programmes.Design, setting, and participantsPopulation-based OPT programmes in two Swedish regions, designed to include men aged between 50 and 74 yr, launched in September 2020 for 50-yr-old men.Outcome measurements and statistical analysisThe number of men invited, the participation rate, and the numbers of magnetic resonance imaging (MRI) scans, urological visits, and biopsies from September 2020 to June 2021 were recorded.Results and limitationsTwo Swedish regions co-designed an OPT programme with a risk-stratified diagnostic algorithm based on prostate-specific antigen (PSA), PSA density, MRI findings, and age. An automated administrative system was developed on a nationwide web-based platform. Invitation letters and test results are automatically generated and sent out by post. Men with PSA ≥3ng/ml, a suspicious MRI lesion, and/or PSA density ≥0.15 ng/ml/cm3 are referred for a prostate biopsy. Test results are registered for quality control and research. By June 2021, a total of 16 515 men were invited, of whom 6309 (38%) participated; 147 had an MRI scan and 39 underwent prostate biopsy. The OPT framework, algorithm, and diagnostic pathways have been working well.ConclusionsWe designed and implemented a framework for OPT with a high grade of automation. The framework and organisational experiences may be of value for others who plan a programme for early detection of PCa.Patient summaryWe describe the implementation of an organised testing programme for early detection of prostate cancer in two Swedish regions. This model is the first of its kind and may serve as a template for similar programmes.

Topics & Concepts

MedicineProstate cancerPopulationProstateProstate-specific antigenBiopsyMedical physicsTest (biology)CancerGynecologyInternal medicineEnvironmental healthBiologyPaleontologyProstate Cancer Diagnosis and TreatmentHealth Promotion and Cardiovascular PreventionProstate Cancer Treatment and Research